Maiwald Blog

文章来自Maiwald博客

Paris, Munich, Milan – first revision of the UPCA adopted

It has been agreed upon for several weeks and was already confirmed at the meeting of the Administrative Committee of the Unified Patent Court (UPC)

Continue reading

Maiwald is pleased to be a member of the UPCLA network

What is the UPCLA network? The UPCLA network, created in 2014, is a non-exclusive network of European law...

Continue reading

To use or not to use – the nuisance of repeated trademark filings

The so-called grace period for use in the EU Trademark Regulation is intended to give applicants the opportunity to protect their trademark and thus an important marketing too...

Continue reading

News on EU Pharmaceutical and Medical Devices Laws

1. New pharmaceutical legislation With the so-called

Continue reading

FCJ (Federal Court of Justice): Current decisions on cease-and-desist declarations according to “Hamburger Brauch” – Part 2

In its judgment of 1 December 2022 (Case No. I ZR 144/21), the FCJ clarified firstly that the delivery of a cease-and-desist declaration with penalty clause c...

Continue reading

The European Patent Office (EPO) has announced that its fees will increase from 1 April 2023

The European Patent Office (EPO) has announced that its fees will increase from 1 April 2023. Most of the fees are increased by 3%. However, the fees for requesting an interna...

Continue reading